| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.15M | 2.32M | 2.15M | 1.79M | 13.16M | 8.24M |
| Gross Profit | 446.00K | 74.46K | 80.00K | -3.23M | 2.66M | 3.78M |
| EBITDA | 10.59M | -5.74M | 9.41M | -33.42M | -4.94M | -2.00M |
| Net Income | 1.09M | -19.78M | 1.09M | -42.37M | -12.83M | 64.44M |
Balance Sheet | ||||||
| Total Assets | 164.72M | 197.46M | 164.72M | 140.02M | 262.91M | 259.30M |
| Cash, Cash Equivalents and Short-Term Investments | 3.20M | 2.07M | 3.20M | 207.00K | 1.44M | 1.15M |
| Total Debt | 48.50M | 53.82M | 48.50M | 41.68M | 33.94M | 18.34M |
| Total Liabilities | 99.09M | 107.84M | 99.09M | 90.04M | 171.26M | 156.21M |
| Stockholders Equity | 65.63M | 89.62M | 65.63M | 49.98M | 91.65M | 103.09M |
Cash Flow | ||||||
| Free Cash Flow | -11.38M | -20.12M | -11.38M | -4.24M | -16.27M | -13.19M |
| Operating Cash Flow | -10.97M | -18.72M | -10.97M | -4.19M | -15.84M | -13.13M |
| Investing Cash Flow | 1.24M | -1.40M | 1.24M | -593.00K | -430.00K | -2.17M |
| Financing Cash Flow | 12.71M | 19.00M | 12.71M | 3.55M | 16.56M | 14.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
51 Neutral | £28.64M | -10.64 | -8.49% | ― | ― | 2.38% | |
50 Neutral | £21.38M | -2.24 | -54.57% | ― | ― | ― | |
47 Neutral | £44.59M | -1.34 | -31.73% | ― | -2.68% | -5.04% | |
46 Neutral | £17.44M | -6.58 | ― | ― | ― | ― | |
45 Neutral | £4.57M | -0.19 | -45.38% | ― | ― | 85.90% | |
43 Neutral | £36.45M | -7.38 | -7.06% | ― | 4.36% | -346.15% |